drugset / Trial / NCT00144066

A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer

NCT00144066

Phase 3 Completed 600 enrolled West Japan Thoracic Oncology Group
RandomizedParallel-groupOpen-labelTreatment

Summary

A randomized phase III trial of platinum-based chemotherapy alone versus platinum-based chemotherapy followed by maintenance therapy with gefitinib in patients with stage IIIB/IV NSCLC.

Timeline

Start
2003-01
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Gefitinib Small molecule

Indications